AGEEF - Halo Labs Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1980
-0.0020 (-1.01%)
At close: 3:58PM EDT
Stock chart is not supported by your current browser
Previous Close0.2000
Open0.1995
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1849 - 0.2100
52 Week Range0.1700 - 0.6800
Volume174,752
Avg. Volume372,331
Market Cap36.867M
Beta (3Y Monthly)-1,720.46
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • Business Wire

    REPEAT/Halo Labs Announces Closing of Second Tranche For Completion Of Aggregate CAD $4 Million Private Placement

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the Company’s press releases of October 7, 2019 and October 11, 2019, Halo has closed a second tranche of the previously announced non-brokered increased private placement of Halo common shares (the “Offering”) at a price of CAD $0.31 per share for additional gross proceeds of approximately CAD $1 million (the “Second Tranche”). The Company previously closed a first tranche of the Offering for gross proceeds of CAD $3 million.

  • Business Wire

    Halo Labs Announces Closing of Second Tranche For Completion Of Aggregate CAD $4 Million Private Placement

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the Company’s press releases of October 7, 2019 and October 11, 2019, Halo has closed a second tranche of the previously announced non-brokered increased private placement of Halo common shares (the “Offering”) at a price of CAD $0.31 per share for additional gross proceeds of approximately CAD $1 million (the “Second Tranche”). The Company previously closed a first tranche of the Offering for gross proceeds of CAD $3 million.

  • Business Wire

    REPEAT/Halo Labs Announces Partnership Agreement with Greeny.com

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces a partnership agreement between Dispensary Track, a Halo Canadian subsidiary, and Greeny.com, a one-stop online marketplace for CBD-based products. Halo has selected Greeny.com to be the CBD products store featured on Dispensary Track’s phone and tablet applications. The Company recently closed on the acquisition of Dispensary Track, a platform that allows customers to electronically interact with dispensaries, thereby reducing wait times and improving customer experience.

  • Business Wire

    Halo Labs Announces Partnership Agreement with Greeny.com

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces a partnership agreement between Dispensary Track, a Halo Canadian subsidiary, and Greeny.com, a one-stop online marketplace for CBD-based products. Halo has selected Greeny.com to be the CBD products store featured on Dispensary Track’s phone and tablet applications. The Company recently closed on the acquisition of Dispensary Track, a platform that allows customers to electronically interact with dispensaries, thereby reducing wait times and improving customer experience.

  • Business Wire

    REPEAT/Halo Announces Closing of the Previously Announced Private Placement For CAD $3 Million Which is Anticipated to Be Upsized To CAD $4 Million Due to Increased Demand and Completion of Acquisition of Cannpos Services Corp.

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the press release dated October 7, 2019 (the “October 7 Press Release”), it has closed the previously announced non-brokered private placement of Halo common shares at a price of CAD $0.31 per share for aggregate gross proceeds of CAD $3 million (the “Private Placement”). Due to increase investor interest, the Company anticipates that the Private Placement will be increased by at least CAD $1 million within the next week. The Company will issue a subsequent press release to announce the closing of any additional tranches of the Private Placement.

  • Business Wire

    Halo Announces Closing of the Previously Announced Private Placement For CAD $3 Million Which is Anticipated to Be Upsized To CAD $4 Million Due to Increased Demand and Completion of Acquisition of Cannpos Services Corp.

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the press release dated October 7, 2019 (the “October 7 Press Release”), it has closed the previously announced non-brokered private placement of Halo common shares at a price of CAD $0.31 per share for aggregate gross proceeds of CAD $3 million (the “Private Placement”). Due to increase investor interest, the Company anticipates that the Private Placement will be increased by at least CAD $1 million within the next week. The Company will issue a subsequent press release to announce the closing of any additional tranches of the Private Placement.

  • Business Wire

    REPEAT/Halo Announces the Agreement to Acquire a Dispensary Application Software Company and a Concurrent Private Placement

    Halo Labs Inc. is pleased to announce it has entered into a definitive agreement to acquire all of the common shares of Cannpos Services Corp.

  • Business Wire

    Halo Announces the Agreement to Acquire a Dispensary Application Software Company and a Concurrent Private Placement

    Halo Labs Inc. is pleased to announce it has entered into a definitive agreement to acquire all of the common shares of Cannpos Services Corp.

  • Business Wire

    Halo to Present at the 2019 US Cannabis Symposium Hosted by Canaccord Genuity in Toronto, Ontario on October 3rd

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces that Kiran Sidhu, CEO and Co-Founder of Halo Labs, will present at the 2019 US Cannabis Symposium hosted by Canaccord Genuity at the Sheraton Centre Toronto Hotel Lower Level in Toronto, Ontario on October 3rd, 2019 at 2:30 PM Eastern Time on Track 1. For more information about the Canaccord Cannabis Conference, or to schedule a one-on-one meeting with Halo Labs management, please contact your Canaccord representative directly, or send an email to Nadine Miller at nmiller@cgf.com. Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry.

  • Business Wire

    REPEAT/Halo Labs Provides Oregon Business Update Company Projects Record September Sales Orders in Oregon

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) announces that in September, its Oregon business unit (“ANM”) will have a record level of monthly sales orders totaling approximately $1.8 million (all figures are USD unless stated otherwise), driven by estimated vape cartridge sales of $539,000. Halo believes that this spike in sales orders partially originates from consumers stockpiling vape products in case a ban is imposed by Oregon. Actual revenue will be lower than $1.8 million in September in Oregon and is estimated to be $1.4 million.

  • Halo Labs Provides Oregon Business Update Company Projects Record September Sales Orders in Oregon
    Business Wire

    Halo Labs Provides Oregon Business Update Company Projects Record September Sales Orders in Oregon

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) announces that in September, its Oregon business unit (“ANM”) will have a record level of monthly sales orders totaling approximately $1.8 million (all figures are USD unless stated otherwise), driven by estimated vape cartridge sales of $539,000. Halo believes that this spike in sales orders partially originates from consumers stockpiling vape products in case a ban is imposed by Oregon. Actual revenue will be lower than $1.8 million in September in Oregon and is estimated to be $1.4 million.

  • Business Wire

    Halo Labs Highlights DabTabsTM Technology 3rd Party Certifications and Testing Given Current Vape Climate

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today provides a statement regarding DabTabsTM technology, certifications, and 3rd party testing reinforcing that DabTabsTM are fundamentally different to current vaporization technologies. “With the recent news headlines surrounding deaths and health issues associated with vaping, Halo is proud to fill and distribute DabTabsTM with full spectrum unadulterated natural extracts,” commented Kiran Sidhu, Halo’s CEO and Co-Founder. Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry.

  • Business Wire

    Halo Provides Update on Bophelo Biosciences Signing and Closing

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide an update to a previous press release on September 4th that the Company anticipates signing definitive documents with Bophelo Biosciences Ltd. (“Bophelo”) in Lesotho, Africa within the next two to three weeks. “The planned acquisition of Bophelo is a very important milestone for Halo. Bophelo’s initial 5-hectare site is almost two times the size of the Evans Creek site in Southern Oregon, and Bophelo’s conditional approval of up to 200 hectares of outdoor grow would be one of largest cannabis cultivation projects worldwide that we know of,” said Kiran Sidhu, CEO and Co-Founder of Halo Labs.

  • Business Wire

    Halo Labs Announces Debt Financing of up to C$10 Million

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced that it has entered into an unsecured debt financing agreement (the “Agreement”) with a private arm’s-length lender (the “Lender”) for a principal amount of up to C$10,000,000. The Agreement is for an initial twelve month term (the “Initial Term”) with interest accruing at a rate of 9%. The Company has the ability to extend the Initial Term for an additional 12 months at an interest rate of 13% following the Initial Term.

  • Business Wire

    Halo Signs Bulk Extract Supply Agreement With Caliva

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into a bulk supply agreement (the “Agreement”) with NC3 Systems (“Caliva”) to provide bulk distillate, bulk live resin and live resin packaged as finished products. Timing and frequency of orders is at the discretion of Caliva. Caliva is the leader in California’s cannabis industry, holding 14 total cannabis licenses, placing products in more than 200 stores state wide and servicing roughly 700,000 total customers throughout the Golden State.

  • Business Wire

    Halo 80 Cent Warrants to Commence Trading on the NEO

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the warrants issued in connection with Halo’s private placement which closed on June 29, 2018 and business combination which closed on October 2, 2018 (the “Warrants”) have been approved for listing on the NEO Exchange. The Warrants are expected to commence trading on or about September 11, 2019 under the symbol HLO.WT.A. “We are pleased that the Warrants have been approved for listing on the NEO Exchange as this will provide additional liquidity for our stakeholders,” said Kiran Sidhu, CEO and Co-Founder.

  • Business Wire

    REPEAT/Halo Announces Update on Bophelo Biosciences

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide an operational update given recent developments at Bophelo Biosciences Ltd. (“Bophelo”) in Lesotho, Africa. Halo’s CEO and Co-Founder, Kiran Sidhu, commented: “I am happy to provide our investors with further insight and updates surrounding our international operations. Halo and Bophelo are in the process of negotiating mutually agreeable definitive agreements and the parties expect to sign such definitive agreements within the next thirty days.

  • Business Wire

    Halo Announces Update on Bophelo Biosciences

    Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to provide an operational update given recent developments at Bophelo Biosciences Ltd. (“Bophelo”) in Lesotho, Africa. Halo’s CEO and Co-Founder, Kiran Sidhu, commented: “I am happy to provide our investors with further insight and updates surrounding our international operations. Halo and Bophelo are in the process of negotiating mutually agreeable definitive agreements and the parties expect to sign such definitive agreements within the next thirty days.